A Study to Evaluate the Combining of Endoscopic Ultrasound Guided Liver Biopsy and Stomach Balloon Placement for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Obesity

Overview

About this study

The purpose of this study is to evaluate the usefulness of combining a core liver biopsy guided by endoscopic ultrasound and stomach balloon placement by endoscope for the diagnosis and treatment of fatty liver disease and obesity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Nonalcoholic steatohepatitis patients with evidence of early fibrosis on MRE-Hepatogram
Referred for an intragastric balloon placement for weight loss

Exclusion Criteria

Age ≤ 21 or ≥ 70 years
Pregnancy, plan for pregnancy or lactating
Previous history of gastric surgery
Current or recent (within 6 months) gastric or duodenal ulcers
Gastroparesis
Liver cirrhosis
Coagulopathy or active use of anticoagulation
Inability to provide a written informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Barham Abu Dayyeh, M.D., M.P.H.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Barham Abu Dayyeh, M.D., M.P.H.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials